Call to action on commercial influence in health
We note the vital role of tests, treatments, and technologies in healthcare and the importance of industry-researcher collaboration. However, extensive financial conflicts of interest are distorting research evidence, medical education, and patient care, and it is time to move towards independence from commercial influence in the production and use of healthcare evidence. We support the development of health system reforms, which would include but are not limited to, ensuring that healthcare products are tested independently from companies which make or market them; that professional education is entirely free from industry support; and that clinical policies, guidelines, and decisions are free from commercial influence.

Please indicate below if you support this call to action. Please also share any thoughts about how this might be achieved.

You are also welcome to send a rapid response to individual articles, or to email us at editorial@bmj.com.

Thank you and best wishes,

Fiona Godlee and Helen Macdonald (Editors, The BMJ)
Ray Moynihan and Lisa Bero (Guest editors of this BMJ collection)
Please add your name
Your answer
Please add your role and/or organisation or affiliation
For example "researcher"
Your answer
Please add your email address if you are happy for us to contact you (this will not be shared publicly)
Your answer
About you
Please tick as many as apply
Please share your ideas on how greater independence could be achieved
Tell us about something, or suggest something which others could do, to foster greater independence from commercial interests. This might include reforms, strategies, or priorities. (We will use these to inform a follow-up article. Please only post your idea here if you are happy to share it publicly with your name).
Your answer
Submit
Never submit passwords through Google Forms.
This form was created inside of BMJ. Report Abuse